Search results
Results from the WOW.Com Content Network
In various patent logs, it is recorded Tesla applied for US patent #613819 for "Filings Tube" (such as Charles Henry Sewall's "Wireless Telegraphy" (New York, 1904)) but it does not seem to have been issued. [7] [8] The Nikola Tesla Museum in Belgrade archives have Tesla prepared material and drawings for patents that he never registered. [7]
Nikola Tesla's Archive consists of over 160,000 original documents and is included in UNESCO Memory of the World Programme. [278] [279] Tesla obtained around 300 patents worldwide for his inventions. [280] Some of Tesla's patents are not accounted for, and various sources have discovered some that have lain hidden in patent archives.
In April 2022, Moderna announced plans to build a $180 million vaccine factory in Montreal, forming a 10-year partnership with the Government of Canada, Quebec, and McGill University to produce 100 million Spikevax doses annually and expand vaccine research capabilities. [38] The plant is scheduled to supply COVID-19 vaccines in the fall of ...
A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the Court of Appeal. ... arguing it was due compensation for ...
The cases are part of a wave of patent lawsuits that have been filed over technology used in the COVID-19 shots, including one filed by Moderna against Pfizer last year. Alnylam to appeal ruling ...
But, on the flip side, the company sued Pfizer and BioNTech last year, accusing the duo of copying technology that Moderna used to make its COVID-19 vaccine. The lawsuits were filed in the U.S., U ...
All RMPs for COVID‑19 vaccines will be published on the EMA's website. [136] The EMA published guidance for developers of potential COVID‑19 vaccines on the clinical evidence to include in marketing authorization applications. [137] In November 2020, the CHMP started a rolling review of the Moderna vaccine for COVID‑19 known as mRNA-1273 ...
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).